The drug is the first to reach the market for recurrent vulvovaginal candidiasis, a condition that affects nearly 140 million women worldwide each year.
FDA Approvals
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
